Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 0 | 237 | 0 | 0 | 0 |
| Gross Profit | N/A | 237 | N/A | N/A | N/A |
| Operating Expenses | 6,582 | 7,328 | 6,434 | 9,938 | 8,612 |
| Operating Income | -6,582 | -7,091 | -6,434 | -9,938 | -8,612 |
| Interest Expense | 287 | 281 | 280 | 288 | 344 |
| Other Income | 29 | 99 | 91 | 67 | 114 |
| Pre-tax Income | -6,840 | -7,273 | -6,623 | -10,159 | -8,842 |
| Net Income Continuous | -6,840 | -7,273 | -6,623 | -10,159 | -8,842 |
| Net Income | $-6,840 | $-7,273 | $-6,623 | $-10,159 | $-8,842 |
| EPS Basic Total Ops | -7.00 | -7.35 | -4.90 | -15.05 | -14.35 |
| EPS Basic Continuous Ops | -6.96 | -7.41 | -4.86 | -15.02 | -14.38 |
| EPS Diluted Total Ops | -7.00 | -7.35 | -4.90 | -15.05 | -14.35 |
| EPS Diluted Continuous Ops | -6.96 | -7.41 | -4.86 | -15.02 | -14.38 |
| EBITDA(a) | $-6,532 | $-7,041 | $-6,380 | $-9,874 | $-8,532 |